2|0|Public
40|$|Dadas las condiciones tecnológicas actuales, el Network Marketing resulta una alternativa, no sólo interesante, sino muy viable. El Network Marketing es una forma de incrementar sustancialmente las ventas y poner al frente del consumidor el producto, llegando de {{una manera}} más rápida y fácil. Este tipo de mercadeo permite abarcar un sector mucho más amplio, sin incrementar los costos. Actualmente el Network Marketing es una herramienta que <b>ha</b> <b>revolucionado</b> el mercado, y ha cambiado estilos de vida. Dada nuestra educación, estamos aferrados a conseguir un “buen empleo”, y tenemos la tendencia de cerrar las puertas ante oportunidades diferentes. Existen muchas maneras en las cuales las personas obtienen sus ingresos, pero la que realmente genera riqueza es la de un trabajo independiente, para obtener recursos y con ellos alcanzar la libertad financiera, mediante inversiones en bienes raíces o acciones. Muchas personas en el Ecuador se encuentran afiliadas a las redes de mercadeo, sobre todo a aquellas que distribuyen productos naturales, medicinales y cosméticos. En nuestro país han ingresado nuevas empresas multinivel, más aún son pocas las compañías ecuatorianas que han aprovechado adecuadamente esta modalidad. En el presente trabajo se pretende no sólo presentar el Network Marketing como una forma de mercadeo, sino, sobre todo, proponerla como un campo para explotar en nuestro territorio. Given the current technology, Network Marketing is an alternative, not only interesting, but very viable. Network Marketing {{is a way}} to {{substantially}} increase sales and bring the consumer the product front, reaching them faster and easier. This type of marketing can cover a wider area, without increasing costs. Currently, Network Marketing is a tool that has revolutionized the market, and changed lifestyles. Considering our education, we are wedded to getting a "good job" and we tend to close doors to different opportunities. There are many ways in which people derive their income, but what really generates wealth is independent work. The next step to independent work is to achieve financial freedom through investing in real estate or stocks. Many people in Ecuador are affiliate to marketing networks, especially those that distribute natural, medicinal and cosmetic products. In our country, new companies have joined multi-level, but few Ecuadorian companies have adequately exploited this modality. In the present work is intended not only to present the Network Marketing as a form of marketing, but, above all, offering an area to exploit in our territory. Conducting a study on compensation plans, tailored to each type of product {{and some of them are}} practiced within the Ecuadorian market. Additionally, through a study of the macro and micro environment I present a viable proposal for Network Marketing in our country. Once the market research and growth potential provided by the Network Marketing, resulting in an attractive idea to solve, in one hand requirements of generating publicity and image positioning, and on the other hand, people’s need to earn from another way, making it a striking proposal to potential partners, to receive residual income through their participation in the network. Espinosa Larreategui, Manuel Agustín, Director...|$|E
40|$|ResumenAproximadamente el 25 % de los pacientes se presentan con cáncer de células renales metastásico (CCRm) al momento del diagnóstico. Los inhibidores con actividad cinasa multitirosina han revolucionado el tratamiento del CCRm desplazando la terapia con citocinas. El sunitinib, inhibidor de la tirosina cinasa, ha mostrado eficacia en términos de supervivencia libre de progresión y supervivencia global, con tasas de respuesta completa de alrededor del 3 %. Presentamos la remisión histológica completa {{posterior}} de sunitinib en CCRm. Masculino 65 años, hipertenso, inicia en 2013 con pérdida ponderal de peso, dolor en hipocondrio derecho, y aumento de volumen abdominal ipsilateral; hallazgo tomográfico tumor en riñón derecho de 24 × 13. 8 × 10 cm, realce 98 UH, conglomerado ganglionar perihiliar; tórax con imagen única heterogénea con centro hiperdenso en segmento apical del pulmón izquierdo. Biopsia renal percutánea con reporte de carcinoma de células renales Fuhrman I. Inicia sunitinib 50 mg vo/ 24 h, 4 semanas, descansando 2 semanas, 3 ciclos. Al termino la tomografía muestra tumor de 10. 2 × 8. 1 × 5. 1 cm hipodenso en centro, calcificaciones periféricas, realce difuso, tórax sin lesiones. Se realiza nefrectomía radical derecha con reporte histopatológico de infiltrado inflamatorio, necrosis, sin evidencia de tumor. Actualmente la integración de cirugía y terapia sistémica representa la mejor opción de tratamiento para muchos pacientes con enfermedad avanzada. El tratamiento del CCRm se <b>ha</b> <b>revolucionado</b> a partir de la era de la terapia blanco, con respuestas parciales de hasta un 30 - 40 %, y respuesta completa en casos aislados. La terapia neoadyuvante ha demostrado disminuir el tamaño tumoral y permitir la cirugía posterior en pacientes seleccionados. AbstractApproximately 25 % of with renal {{cell carcinoma}} have already reached the metastatic phase of disease (mRCC) {{at the time of}} diagnosis. Multi-targeted tyrosine kinase inhibitors have revolutionised the treatment of mRCC, replacing cytokine therapy. Sunitinib, a tyrosine kinase inhibitor has shown to be effective in terms of progression free survival and overall survival, with complete response rates of around 3 %. A case is presented of a complete histological response after sunitinib in mRCC. A 65 year-old hypertensive man, who in 2013 began with a considerable loss of weight, pain in the right hypochondrium, and an increase in ipsilateral abdominal volume. The computed tomography found a tumour of 24 × 13. 8 × 10 cm in the right kidney, with 98 HU enhancement and a peri-hilar lymph node conglomerate. The thorax showed a single heterogeneous image with a hyperdense centre in the apical segment of the left lung. The percutaneous renal biopsy reported a Fuhrman grade I {{renal cell carcinoma}}. Sunitinib was started at 50 mg orally every 24 hours for 4 weeks, resting for 2 weeks, for 3 cycles. At the end of the treatment the tomography showed a tumour of 10. 2 × 8. 1 × 5. 1 cm hyperdense in the centre, peripheral calcifications, diffuse enhancement, and the thorax with no lesions. A right radical nephrectomy was performed, with the histopathology reporting an inflammatory infiltrate, necrosis, and with no evidence of a tumour. The combination of surgery and systemic therapy is currently the best treatment option for many patients with advanced disease. The treatment of mRCC has been revolutionised from the era of blanket therapy, with up to 30 % - 40 % partial responses, and a complete response in isolated cases. Neoadjuvant therapy has been shown to decrease tumour size and enables surgery to be performed in selected patients...|$|E

